» Articles » PMID: 20029420

BRCA1 and Its Toolbox for the Maintenance of Genome Integrity

Overview
Date 2009 Dec 24
PMID 20029420
Citations 292
Authors
Affiliations
Soon will be listed here.
Abstract

The breast and ovarian cancer type 1 susceptibility protein (BRCA1) has pivotal roles in the maintenance of genome stability. Studies support that BRCA1 exerts its tumour suppression function primarily through its involvement in cell cycle checkpoint control and DNA damage repair. In addition, recent proteomic and genetic studies have revealed the presence of distinct BRCA1 complexes in vivo, each of which governs a specific cellular response to DNA damage. Thus, BRCA1 is emerging as the master regulator of the genome through its ability to execute and coordinate various aspects of the DNA damage response.

Citing Articles

Long Intergenic Non-Coding RNAs and in Breast Cancer Pathogenesis: Neighboring Companions or Nemeses?.

Fadebi O, Miya T, Khanyile R, Dlamini Z, Marima R Noncoding RNA. 2025; 11(1).

PMID: 39997609 PMC: 11857994. DOI: 10.3390/ncrna11010009.


Recent advancements in nanomaterial-based biosensors for diagnosis of breast cancer: a comprehensive review.

Yazdani Y, Jalali F, Tahmasbi H, Akbari M, Talebi N, Shahrtash S Cancer Cell Int. 2025; 25(1):50.

PMID: 39966938 PMC: 11834589. DOI: 10.1186/s12935-025-03663-8.


Breast cancer: pathogenesis and treatments.

Xiong X, Zheng L, Ding Y, Chen Y, Cai Y, Wang L Signal Transduct Target Ther. 2025; 10(1):49.

PMID: 39966355 PMC: 11836418. DOI: 10.1038/s41392-024-02108-4.


Incidence and risk factors of pain following breast cancer surgery: a retrospective national inpatient sample database study.

Suo S, Liu R, Yu X, Wang J, Wang M, Zhang Y BMC Womens Health. 2024; 24(1):583.

PMID: 39472876 PMC: 11520449. DOI: 10.1186/s12905-024-03430-3.


Whole‑exome sequencing insights into synchronous bilateral breast cancer with discordant molecular subtypes.

Hu S, Gao B, Li Z, Yuan Y Oncol Lett. 2024; 28(6):595.

PMID: 39430730 PMC: 11487496. DOI: 10.3892/ol.2024.14728.


References
1.
Xia B, Dorsman J, Ameziane N, de Vries Y, Rooimans M, Sheng Q . Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet. 2007; 39(2):159-61. DOI: 10.1038/ng1942. View

2.
Chen L, Nievera C, Lee A, Wu X . Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J Biol Chem. 2008; 283(12):7713-20. DOI: 10.1074/jbc.M710245200. View

3.
Yarden R, Brody L . BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci U S A. 1999; 96(9):4983-8. PMC: 21803. DOI: 10.1073/pnas.96.9.4983. View

4.
Thorslund T, West S . BRCA2: a universal recombinase regulator. Oncogene. 2007; 26(56):7720-30. DOI: 10.1038/sj.onc.1210870. View

5.
Celeste A, Difilippantonio S, Difilippantonio M, Fernandez-Capetillo O, Pilch D, Sedelnikova O . H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell. 2003; 114(3):371-383. PMC: 4737479. DOI: 10.1016/s0092-8674(03)00567-1. View